{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:35:26Z","timestamp":1773920126017,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.prp.2020.153291","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T02:10:12Z","timestamp":1605492612000},"page":"153291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Decreased infiltration of CD4+ Th1 cells indicates a good response to ursodeoxycholic acid (UDCA) in primary biliary cholangitis"],"prefix":"10.1016","volume":"217","author":[{"given":"Kangjie","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junpeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaijing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danhui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linni","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zengshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prp.2020.153291_bib0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1055\/s-0039-1697617","article-title":"The pathogenesis of primary biliary cholangitis: a comprehensive review","volume":"40","author":"Lleo","year":"2020","journal-title":"Semin. Liver Dis."},{"issue":"9377","key":"10.1016\/j.prp.2020.153291_bib0010","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(03)13808-1","article-title":"Primary biliary cirrhosis","volume":"362","author":"Talwalkar","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.prp.2020.153291_bib0015","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"25","key":"10.1016\/j.prp.2020.153291_bib0020","doi-asserted-by":"crossref","first-page":"7683","DOI":"10.3748\/wjg.v21.i25.7683","article-title":"Primary biliary cirrhosis: clinical and laboratory criteria for its diagnosis","volume":"21","author":"Reshetnyak","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.prp.2020.153291_bib0025","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/liv.13294","article-title":"Old and new treatments for primary biliary cholangitis","volume":"37","author":"Chascsa","year":"2017","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.prp.2020.153291_bib0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.prp.2020.153291_bib0035","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1136\/gutjnl-2017-315259","article-title":"The British Society of Gastroenterology\/UK-PBC primary biliary cholangitis treatment and management guidelines","volume":"67","author":"Hirschfield","year":"2018","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.prp.2020.153291_bib0040","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/hep.30552","article-title":"Bezafibrate improves GLOBE and UK-PBC scores and long-term outcomes in patients with primary biliary cholangitis","volume":"70","author":"Honda","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.prp.2020.153291_bib0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ajg.2017.287","article-title":"Effects of bezafibrate on outcome and pruritus in primary biliary cholangitis with suboptimal ursodeoxycholic acid response","volume":"113","author":"Reig","year":"2018","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.prp.2020.153291_bib0050","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/hep.28932","article-title":"Long-term clinical impact and cost-effectiveness of obeticholic acid for the treatment of primary biliary cholangitis","volume":"65","author":"Samur","year":"2017","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.prp.2020.153291_bib0055","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/ajg.2010.216","article-title":"Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis","volume":"105","author":"Kumagi","year":"2010","journal-title":"Am. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.prp.2020.153291_bib0060","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s12072-017-9819-9","article-title":"A brief review on prognostic models of primary biliary cholangitis","volume":"11","author":"Chen","year":"2017","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.prp.2020.153291_bib0065","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1034\/j.1600-0528.2002.017402.x","article-title":"Primary biliary cirrhosis: an orchestrated immune response against epithelial cells","volume":"174","author":"Gershwin","year":"2000","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.prp.2020.153291_bib0070","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1042\/CS20181123","article-title":"Immunological abnormalities in patients with primary biliary cholangitis","volume":"133","author":"Ma","year":"2019","journal-title":"Clin. Sci."},{"issue":"4","key":"10.1016\/j.prp.2020.153291_bib0075","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1055\/s-2007-1007284","article-title":"Pathology and immunopathology of primary biliary cirrhosis with emphasis on bile duct lesions: recent progress","volume":"15","author":"Nakanuma","year":"1995","journal-title":"Semin. Liver Dis."},{"issue":"1","key":"10.1016\/j.prp.2020.153291_bib0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1568-9972(02)00122-2","article-title":"T cell immunity and primary biliary cirrhosis","volume":"2","author":"Ishibashi","year":"2003","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.prp.2020.153291_bib0085","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4049\/jimmunol.146.1.89","article-title":"Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis","volume":"146","author":"Van de Water","year":"1991","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.prp.2020.153291_bib0090","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/hep.23238","article-title":"B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice","volume":"50","author":"Moritoki","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.prp.2020.153291_bib0095","doi-asserted-by":"crossref","first-page":"102328","DOI":"10.1016\/j.jaut.2019.102328","article-title":"The challenges of primary biliary cholangitis: what is new and what needs to be done","volume":"105","author":"Terziroli","year":"2019","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.prp.2020.153291_bib0100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1440-1827.2009.02500.x","article-title":"Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: interobserver agreement","volume":"60","author":"Nakanuma","year":"2010","journal-title":"Pathol. Int."},{"issue":"25","key":"10.1016\/j.prp.2020.153291_bib0105","doi-asserted-by":"crossref","first-page":"7683","DOI":"10.3748\/wjg.v21.i25.7683","article-title":"Primary biliary cirrhosis: clinical and laboratory criteria for its diagnosis","volume":"21","author":"Reshetnyak","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.prp.2020.153291_bib0110","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jhep.2019.04.001","article-title":"Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis","volume":"71","author":"Harms","year":"2019","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.prp.2020.153291_bib0115","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cld.2017.06.005","article-title":"An update on the treatment and follow-up of patients with primary biliary cholangitis","volume":"21","author":"Burman","year":"2017","journal-title":"Clin. Liver Dis."},{"issue":"3","key":"10.1016\/j.prp.2020.153291_bib0120","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/hep.28932","article-title":"Long-term clinical impact and cost-effectiveness of obeticholic acid for the treatment of primary biliary cholangitis","volume":"65","author":"Samur","year":"2017","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.prp.2020.153291_bib0125","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/liv.14165","article-title":"Additional fibrate treatment in UDCA-refractory PBC patients","volume":"39","author":"Chung","year":"2019","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.prp.2020.153291_bib0130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/icb.2010.126","article-title":"The autoimmunity of primary biliary cirrhosis and the clonal selection theory","volume":"89","author":"Selmi","year":"2011","journal-title":"Immunol. Cell Biol."},{"issue":"1","key":"10.1016\/j.prp.2020.153291_bib0135","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/07853890310018467","article-title":"Autoimmunity and environmental factors in the pathogenesis of primary biliary cirrhosis","volume":"36","author":"Kita","year":"2004","journal-title":"Ann. Med."},{"issue":"5","key":"10.1016\/j.prp.2020.153291_bib0140","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/hep.26979","article-title":"IL-12\/Th1 and IL-23\/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.prp.2020.153291_bib0145","first-page":"129","article-title":"[The characteristics of peripheral lymphocytic subsets and cytokines in primary biliary and their changes to drug treatment.]","volume":"49","author":"Tang","year":"2010","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"6","key":"10.1016\/j.prp.2020.153291_bib0150","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/hep.20705","article-title":"Th1 cytokine-induced downregulation of PPARgamma in human biliary cells relates to cholangitis in primary biliary cirrhosis","volume":"41","author":"Harada","year":"2005","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.prp.2020.153291_bib0155","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S2468-1253(18)30163-8","article-title":"Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score","volume":"3","author":"Carbone","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.prp.2020.153291_bib0160","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/jgh.14900","article-title":"IgM response is a prognostic biomarker of primary biliary cholangitis treated with ursodeoxycholic acid and bezafibrate","volume":"35","author":"Takano","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.prp.2020.153291_bib0165","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/apt.13465","article-title":"Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes","volume":"43","author":"Cheung","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.prp.2020.153291_bib0170","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/jgh.13534","article-title":"Evidence for the association between IgG-antimitochondrial antibody and biochemical response to ursodeoxycholic acid treatment in primary biliary cholangitis","volume":"32","author":"Tang","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.prp.2020.153291_bib0175","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/apt.13244","article-title":"Serum vitamin D level is associated with disease severity and response to ursodeoxycholic acid in primary biliary cirrhosis","volume":"42","author":"Guo","year":"2015","journal-title":"Aliment. Pharmacol. Ther."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033820321464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033820321464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:43:30Z","timestamp":1759733010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033820321464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":35,"alternative-id":["S0344033820321464"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2020.153291","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased infiltration of CD4+ Th1 cells indicates a good response to ursodeoxycholic acid (UDCA) in primary biliary cholangitis","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2020.153291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153291"}}